Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol.

Stankiewicz Karita HC, Hauge K, Magaret A, Mao C, Schouten J, Grieco V, Xi LF, Galloway DA, Madeleine MM, Wald A.

JAMA Netw Open. 2019 Apr 5;2(4):e190819. doi: 10.1001/jamanetworkopen.2019.0819.

2.

Gynecologic cancers and solid organ transplantation.

Liao JB, Fisher CE, Madeleine MM.

Am J Transplant. 2019 May;19(5):1266-1277. doi: 10.1111/ajt.15292. Epub 2019 Apr 4. Review.

PMID:
30725527
3.

HLA and KIR Associations of Cervical Neoplasia.

Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Garland SM, Tabrizi SN, Wentzensen N, Sitas F, Trimble C, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA, Duncan EL, Sun YP, Leo PJ.

J Infect Dis. 2018 Nov 5;218(12):2006-2015. doi: 10.1093/infdis/jiy483.

PMID:
30099516
4.

Risk of lip cancer after solid organ transplantation in the United States.

Laprise C, Cahoon EK, Lynch CF, Kahn AR, Copeland G, Gonsalves L, Madeleine MM, Pfeiffer RM, Engels EA.

Am J Transplant. 2019 Jan;19(1):227-237. doi: 10.1111/ajt.15052. Epub 2018 Sep 5.

PMID:
30074684
5.

Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States.

Tota JE, Engels EA, Madeleine MM, Clarke CA, Lynch CF, Ortiz AP, Hernandez BY, Chaturvedi AK.

Cancer. 2018 Jun 15;124(12):2515-2522. doi: 10.1002/cncr.31359. Epub 2018 Apr 12.

6.

Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2018 Mar 1;14(3):e1007257. doi: 10.1371/journal.pgen.1007257. eCollection 2018 Mar.

7.

Epidemiology of keratinocyte carcinomas after organ transplantation.

Madeleine MM, Patel NS, Plasmeijer EI, Engels EA, Bouwes Bavinck JN, Toland AE, Green AC; the Keratinocyte Carcinoma Consortium (KeraCon) Immunosuppression Working Group.

Br J Dermatol. 2017 Nov;177(5):1208-1216. doi: 10.1111/bjd.15931. Epub 2017 Oct 10. Review.

PMID:
28994104
8.

Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2017 Aug 14;13(8):e1006866. doi: 10.1371/journal.pgen.1006866. eCollection 2017 Aug. Erratum in: PLoS Genet. 2018 Mar 1;14 (3):e1007257.

9.

Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.

Zamoiski RD, Yanik E, Gibson TM, Cahoon EK, Madeleine MM, Lynch CF, Gustafson S, Goodman MT, Skeans M, Israni AK, Engels EA, Morton LM.

Cancer Res. 2017 Aug 1;77(15):4196-4203. doi: 10.1158/0008-5472.CAN-16-3291. Epub 2017 Jun 14.

10.

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.

Buas MF, He Q, Johnson LG, Onstad L, Levine DM, Thrift AP, Gharahkhani P, Palles C, Lagergren J, Fitzgerald RC, Ye W, Caldas C, Bird NC, Shaheen NJ, Bernstein L, Gammon MD, Wu AH, Hardie LJ, Pharoah PD, Liu G, Iyer P, Corley DA, Risch HA, Chow WH, Prenen H, Chegwidden L, Love S, Attwood S, Moayyedi P, MacDonald D, Harrison R, Watson P, Barr H, deCaestecker J, Tomlinson I, Jankowski J, Whiteman DC, MacGregor S, Vaughan TL, Madeleine MM.

Gut. 2017 Oct;66(10):1739-1747. doi: 10.1136/gutjnl-2016-311622. Epub 2016 Aug 2.

11.

Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3).

Madeleine MM, Johnson LG, Doody DR, Tipton ER, Carter JJ, Galloway DA.

J Low Genit Tract Dis. 2016 Jul;20(3):257-60. doi: 10.1097/LGT.0000000000000227.

12.

Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort.

Coghill AE, Johnson LG, Berg D, Resler AJ, Leca N, Madeleine MM.

Am J Transplant. 2016 Feb;16(2):565-73. doi: 10.1111/ajt.13596.

13.

A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.

Hardikar S, Johnson LG, Malkki M, Petersdorf EW, Galloway DA, Schwartz SM, Madeleine MM.

Gynecol Oncol. 2015 Oct;139(1):90-6. doi: 10.1016/j.ygyno.2015.07.110. Epub 2015 Aug 1.

14.

Risk of merkel cell carcinoma after solid organ transplantation.

Clarke CA, Robbins HA, Tatalovich Z, Lynch CF, Pawlish KS, Finch JL, Hernandez BY, Fraumeni JF Jr, Madeleine MM, Engels EA.

J Natl Cancer Inst. 2015 Jan 8;107(2). pii: dju382. doi: 10.1093/jnci/dju382. Print 2015 Feb.

15.

Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.

Paulson KG, Tegeder A, Willmes C, Iyer JG, Afanasiev OK, Schrama D, Koba S, Thibodeau R, Nagase K, Simonson WT, Seo A, Koelle DM, Madeleine M, Bhatia S, Nakajima H, Sano S, Hardwick JS, Disis ML, Cleary MA, Becker JC, Nghiem P.

Cancer Immunol Res. 2014 Nov;2(11):1071-9. doi: 10.1158/2326-6066.CIR-14-0005. Epub 2014 Aug 12.

16.

Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma.

Safaeian M, Johnson LG, Yu K, Wang SS, Gravitt PE, Hansen JA, Carrington M, Schwartz SM, Gao X, Hildesheim A, Madeleine MM.

Front Oncol. 2014 Jun 19;4:119. doi: 10.3389/fonc.2014.00119. eCollection 2014.

17.

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants.

Madeleine MM, Carter JJ, Johnson LG, Wipf GC, Davis C, Berg D, Nelson K, Daling JR, Schwartz SM, Galloway DA.

Cancer Med. 2014 Oct;3(5):1440-7. doi: 10.1002/cam4.280. Epub 2014 Jun 10.

18.

Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.

Edlefsen KL, Martínez-Maza O, Madeleine MM, Magpantay L, Mirick DK, Kopecky KJ, LaCroix AZ, De Roos AJ.

Int J Cancer. 2014 Aug 15;135(4):913-22. doi: 10.1002/ijc.28724. Epub 2014 Feb 3.

19.

Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women.

Bodelon C, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM.

Int J Mol Epidemiol Genet. 2013 Nov 28;4(4):218-27. eCollection 2013.

20.

HPV-related cancers after solid organ transplantation in the United States.

Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA.

Am J Transplant. 2013 Dec;13(12):3202-9. doi: 10.1111/ajt.12472. Epub 2013 Oct 1.

21.

Contribution of HIV infection to mortality among cancer patients in Uganda.

Coghill AE, Newcomb PA, Madeleine MM, Richardson BA, Mutyaba I, Okuku F, Phipps W, Wabinga H, Orem J, Casper C.

AIDS. 2013 Nov 28;27(18):2933-42. doi: 10.1097/01.aids.0000433236.55937.cb.

22.

Invited commentary: Biological and clinical insights from epidemiologic research into HIV, HPV, and anal cancer.

Engels EA, Madeleine MM.

Am J Epidemiol. 2013 Sep 15;178(6):885-7. doi: 10.1093/aje/kwt149. Epub 2013 Jul 30.

23.

Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort.

De Roos AJ, Martínez-Maza O, Jerome KR, Mirick DK, Kopecky KJ, Madeleine MM, Magpantay L, Edlefsen KL, Lacroix AZ.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1747-55. doi: 10.1158/1055-9965.EPI-13-0240. Epub 2013 Jul 24.

24.

Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Galloway DA, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2014 Jan 15;134(2):437-44. doi: 10.1002/ijc.28364. Epub 2013 Aug 5.

25.

Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.

Resler AJ, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM.

BMC Cancer. 2013 May 1;13:219. doi: 10.1186/1471-2407-13-219.

26.

Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2013 Jul;133(1):201-13. doi: 10.1002/ijc.28000. Epub 2013 Feb 12.

27.

Cohort profile: the skin cancer after organ transplant study.

Madeleine MM, Johnson LG, Daling JR, Schwartz SM, Carter JJ, Berg D, Nelson K, Davis CL, Galloway DA.

Int J Epidemiol. 2013 Dec;42(6):1669-77. doi: 10.1093/ije/dys179. Epub 2012 Nov 21.

28.

A history of allergies is associated with reduced risk of oral squamous cell carcinoma.

Stott-Miller M, Chen C, Doody DR, Carter JL, Galloway DA, Madeleine MM, Schwartz SM.

Cancer Causes Control. 2012 Dec;23(12):1911-9. doi: 10.1007/s10552-012-0068-x. Epub 2012 Sep 26.

29.

Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma.

De Roos AJ, Mirick DK, Edlefsen KL, LaCroix AZ, Kopecky KJ, Madeleine MM, Magpantay L, Martínez-Maza O.

Cancer Res. 2012 Sep 15;72(18):4733-43. Epub 2012 Jul 30.

30.

Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study.

Guo F, Liu Y, Wang X, He Z, Weiss NS, Madeleine MM, Liu F, Tian X, Song Y, Pan Y, Ning T, Yang H, Shi X, Lu C, Cai H, Ke Y.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):780-5. doi: 10.1158/1055-9965.EPI-11-1206. Epub 2012 Feb 15.

31.

Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Malkki M, Petersdorf EW, Schwartz SM.

Gynecol Oncol. 2012 Mar;124(3):525-8. doi: 10.1016/j.ygyno.2011.11.017. Epub 2011 Nov 28.

32.

Spectrum of cancer risk among US solid organ transplant recipients.

Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M.

JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.

33.

Humoral immunomodulatory effect of influenza vaccine in potential blood donors: implications for transfusion safety.

Delaney M, Warner P, Nelson K, Gleckler C, Price T, Madeleine M.

Transfus Med. 2011 Dec;21(6):378-84. doi: 10.1111/j.1365-3148.2011.01097.x. Epub 2011 Aug 31.

PMID:
21883543
34.

No evidence for human papillomavirus in the etiology of colorectal polyps.

Burnett-Hartman AN, Newcomb PA, Mandelson MT, Galloway DA, Madeleine MM, Wurscher MA, Carter JJ, Makar KW, Potter JD, Schwartz SM.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2288-97. doi: 10.1158/1055-9965.EPI-11-0450. Epub 2011 Aug 4.

35.

Parity and HLA alleles in risk of rheumatoid arthritis.

Guthrie KA, Gammill HS, Madeleine MM, Dugowson CE, Nelson JL.

Chimerism. 2011 Jan;2(1):11-5. doi: 10.4161/chim.2.1.15424.

36.

Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.

Madeleine MM, Johnson LG, Malkki M, Resler AJ, Petersdorf EW, McKnight B, Malone KE.

Breast Cancer Res Treat. 2011 Oct;129(3):887-99. doi: 10.1007/s10549-011-1520-4. Epub 2011 Apr 27.

37.

Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.

Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR, Koelle DM, Galloway DA, Leonard JH, Madeleine MM, Argenyi ZB, Disis ML, Becker JC, Cleary MA, Nghiem P.

J Clin Oncol. 2011 Apr 20;29(12):1539-46. doi: 10.1200/JCO.2010.30.6308. Epub 2011 Mar 21.

38.

Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.

Johnson LG, Schwartz SM, Malkki M, Du Q, Petersdorf EW, Galloway DA, Madeleine MM.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):199-207. doi: 10.1158/1055-9965.EPI-10-0779. Epub 2010 Nov 11.

39.

Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.

Paulson KG, Carter JJ, Johnson LG, Cahill KW, Iyer JG, Schrama D, Becker JC, Madeleine MM, Nghiem P, Galloway DA.

Cancer Res. 2010 Nov 1;70(21):8388-97. doi: 10.1158/0008-5472.CAN-10-2128. Epub 2010 Oct 19.

40.

Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.

Maley SN, Schwartz SM, Johnson LG, Malkki M, Du Q, Daling JR, Li SS, Zhao LP, Petersdorf EW, Madeleine MM.

Int J Immunogenet. 2009 Dec;36(6):367-75. doi: 10.1111/j.1744-313X.2009.00877.x. Epub 2009 Sep 24.

41.

Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma.

Carter JJ, Paulson KG, Wipf GC, Miranda D, Madeleine MM, Johnson LG, Lemos BD, Lee S, Warcola AH, Iyer JG, Nghiem P, Galloway DA.

J Natl Cancer Inst. 2009 Nov 4;101(21):1510-22. doi: 10.1093/jnci/djp332. Epub 2009 Sep 23.

42.

Is the incidence of invasive vulvar cancer increasing in the United States?

Bodelon C, Madeleine MM, Voigt LF, Weiss NS.

Cancer Causes Control. 2009 Nov;20(9):1779-82. doi: 10.1007/s10552-009-9418-8. Epub 2009 Aug 13.

43.

Risk of human papillomavirus-associated cancers among persons with AIDS.

Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA.

J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30. doi: 10.1093/jnci/djp205. Epub 2009 Jul 31.

44.

TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.

Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das BR, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y, Pegoraro R, Pillai MR, Ranzani G, Rezza G, Rosenthal AN, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-Ishida W, Shirasawa H, Snijders PJ, Stoler MH, Suárez-Rincón AE, Szarka K, Tachezy R, Ueda M, van der Zee AG, von Knebel Doeberitz M, Wu MT, Yamashita T, Zehbe I, Blettner M.

Lancet Oncol. 2009 Aug;10(8):772-84. doi: 10.1016/S1470-2045(09)70187-1. Epub 2009 Jul 20.

PMID:
19625214
45.

Age of diagnosis of squamous cell cervical carcinoma and early sexual experience.

Edelstein ZR, Madeleine MM, Hughes JP, Johnson LG, Schwartz SM, Galloway DA, Carter JJ, Koutsky LA.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1070-6. doi: 10.1158/1055-9965.EPI-08-0707. Epub 2009 Mar 24.

46.

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.

De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S.

Int J Cancer. 2009 Apr 1;124(7):1626-36. doi: 10.1002/ijc.24116.

47.

Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Lanoy E, Dores GM, Madeleine MM, Toro JR, Fraumeni JF Jr, Engels EA.

AIDS. 2009 Jan 28;23(3):385-93. doi: 10.1097/QAD.0b013e3283213046.

48.

Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Malkki M, Wilkerson HW, Farin FM, Carter JJ, Galloway DA, Daling JR, Petersdorf EW, Schwartz SM.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1790-9. doi: 10.1158/1055-9965.EPI-07-2753.

49.

A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.

Insinga RP, Liaw KL, Johnson LG, Madeleine MM.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1611-22. doi: 10.1158/1055-9965.EPI-07-2922. Review.

50.

Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.

Madeleine MM, Johnson LG, Smith AG, Hansen JA, Nisperos BB, Li S, Zhao LP, Daling JR, Schwartz SM, Galloway DA.

Cancer Res. 2008 May 1;68(9):3532-9. doi: 10.1158/0008-5472.CAN-07-6471.

Supplemental Content

Loading ...
Support Center